MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNAs (miRs) play crucial roles in cancer development, including osteosarcoma (OS).
• The specific molecular mechanisms of miRs in OS progression require further elucidation.
• miR-148a has been implicated in various cancers, but its role in OS is not fully understood.

Purpose of the Study:

• To investigate the function of miR-148a in osteosarcoma (OS).
• To identify the molecular targets and mechanisms underlying miR-148a's role in OS.
• To evaluate the potential of the miR-148a/ROCK1 axis as a therapeutic target for OS.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to assess miR-148a and ROCK1 expression in OS tissues and cell lines.
• Western blotting to analyze ROCK1 protein levels.
• Cell proliferation, migration, and invasion assays (e.g., MTT, Transwell assays).
• In vivo tumor xenograft models in nude mice to assess the effect of miR-148a on tumor growth.

Main Results:

• miR-148a was significantly downregulated in OS tissues and cell lines compared to normal controls.
• Low miR-148a expression correlated with advanced tumor stage and poor patient prognosis.
• Rho-associated coiled-coil kinase 1 (ROCK1) was identified as a direct target of miR-148a.
• miR-148a suppressed OS cell proliferation, migration, and invasion.
• Overexpression of ROCK1 reversed the inhibitory effects of miR-148a.
• In vivo studies showed that miR-148a overexpression inhibited OS tumor growth.

Conclusions:

• miR-148a functions as a tumor suppressor in osteosarcoma, at least partly through targeting ROCK1.
• The miR-148a/ROCK1 signaling pathway represents a promising therapeutic target for osteosarcoma treatment.